171 related articles for article (PubMed ID: 32303954)
21. Multimodality Radionuclide Imaging in a Patient With Hereditary Paraganglioma-Pheochromocytoma Syndrome.
Yim SY; Moncayo VM; Pasquel FJ; Halkar RK
Clin Nucl Med; 2017 Dec; 42(12):964-965. PubMed ID: 28902732
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations.
Oudijk L; Neuhofer CM; Lichtenauer UD; Papathomas TG; Korpershoek E; Stoop H; Oosterhuis JW; Smid M; Restuccia DF; Robledo M; de Cubas AA; Mannelli M; Gimenez-Roqueplo AP; Dinjens WN; Beuschlein F; de Krijger RR
Eur J Endocrinol; 2015 Jul; 173(1):43-52. PubMed ID: 25916394
[TBL] [Abstract][Full Text] [Related]
23. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms.
Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP
Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821
[TBL] [Abstract][Full Text] [Related]
24. Endosalpingiosis Is Negative for GATA3.
White MJ; Vang R; Argani P; Cimino-Mathews A
Arch Pathol Lab Med; 2021 Nov; 145(11):1448-1452. PubMed ID: 33571371
[TBL] [Abstract][Full Text] [Related]
25. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era.
Pillai S; Gopalan V; Smith RA; Lam AK
Crit Rev Oncol Hematol; 2016 Apr; 100():190-208. PubMed ID: 26839173
[TBL] [Abstract][Full Text] [Related]
26. Pheochromocytomas and paragangliomas in humans and dogs.
Galac S; Korpershoek E
Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
[TBL] [Abstract][Full Text] [Related]
27. GATA3 Immunohistochemistry for Distinguishing Sarcomatoid and Desmoplastic Mesothelioma From Sarcomatoid Carcinoma of the Lung.
Berg KB; Churg A
Am J Surg Pathol; 2017 Sep; 41(9):1221-1225. PubMed ID: 28614203
[TBL] [Abstract][Full Text] [Related]
28. Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Ferrara AM; Lombardi G; Pambuku A; Meringolo D; Bertorelle R; Nardin M; Schiavi F; Iacobone M; Opocher G; Zagonel V; Zovato S
Anticancer Drugs; 2018 Jan; 29(1):102-105. PubMed ID: 29099418
[TBL] [Abstract][Full Text] [Related]
29. [Application of immunohistochemistry for p16 and GATA3 and molecular HPV typing in diagnosis of secondary bladder involvement by cervical carcinoma].
Huang RF; He C; Zhu WF; Li Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2017 Jun; 46(6):388-392. PubMed ID: 28591985
[No Abstract] [Full Text] [Related]
30. The Expression of Snail, Galectin-3, and IGF1R in the Differential Diagnosis of Benign and Malignant Pheochromocytoma and Paraganglioma.
Deng L; Chen T; Xu H; Li Y; Deng M; Mo D; Tian H; Ren Y
Biomed Res Int; 2020; 2020():4150735. PubMed ID: 32190664
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytoma and Paraganglioma: Genetics, Diagnosis, and Treatment.
Fishbein L
Hematol Oncol Clin North Am; 2016 Feb; 30(1):135-50. PubMed ID: 26614373
[TBL] [Abstract][Full Text] [Related]
32. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
[TBL] [Abstract][Full Text] [Related]
33. Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.
Cheung VKY; Gill AJ; Chou A
Endocr Pathol; 2018 Jun; 29(2):169-175. PubMed ID: 29779206
[TBL] [Abstract][Full Text] [Related]
34. Retroperitoneal paraganglioma: a chameleon masquerading as an adrenal pheochromocytoma.
Parmar K; Chandna A; Kumar S
Ann R Coll Surg Engl; 2019 Feb; 101(2):e62-e65. PubMed ID: 30371110
[TBL] [Abstract][Full Text] [Related]
35. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
36. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
37. Adrenal and extra-adrenal nonfunctioning composite pheochromocytoma/paraganglioma with immunohistochemical ectopic hormone expression: comparison of two cases.
Gong J; Wang X; Chen X; Chen N; Huang R; Lu C; Chen D; Zeng H; Zhou Q
Urol Int; 2010; 85(3):368-72. PubMed ID: 20829582
[TBL] [Abstract][Full Text] [Related]
38. Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma.
Chang A; Brimo F; Montgomery EA; Epstein JI
Hum Pathol; 2013 Aug; 44(8):1563-8. PubMed ID: 23453625
[TBL] [Abstract][Full Text] [Related]
39. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
40. Dopamine β-hydroxylase: An Essential and Optimal Immunohistochemical Marker for Pheochromocytoma and Sympathetic Paraganglioma.
Kimura N
Endocr Pathol; 2021 Jun; 32(2):258-261. PubMed ID: 33405069
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
